NAICS code
Pharmaceutical Preparation Manufacturing
- NAICS code
- 325412
- Latest action
- Aug 8, 2026
Fewer than the minimum comparable awards under this NAICS code.
Largest awards under this code
| Award | Contractor | Agency | Place | First action | Current value |
|---|---|---|---|---|---|
| 36C24026K1008 EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 MAY | MCKESSON CORPORATION | Department of Veterans Affairs | TX | May 1, 2026 | $1,398,025,092 |
| HHSO100201700019C BAVARIAN NORDIC MOD 21 | BAVARIAN NORDIC A/S | Department of Health and Human Services | — | May 11, 2026 | $1,264,240,981 |
| 36C24026K1009 EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 JUNE | MCKESSON CORPORATION | Department of Veterans Affairs | TX | Jun 1, 2026 | $1,191,973,258 |
| 36C24026K1007 EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 APRIL | MCKESSON CORPORATION | Department of Veterans Affairs | TX | Apr 1, 2026 | $1,191,348,081 |
| 36C24026K1006 EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 MARCH | MCKESSON CORPORATION | Department of Veterans Affairs | TX | Mar 1, 2026 | $1,175,683,451 |
| 75A50120C00092 THE PURPOSE OF THIS ACTION IS TO UPDATE THE PLANNED DEFINITIZATION DATE IN P0022 FROM MARCH 3, 2026 TO MAY 3, 2026 | PHLOW CORP. | Department of Health and Human Services | VA | Mar 3, 2026 | $708,849,576 |
| 75A50119C00037 VACCINIA IMMUNE GLOBULIN INTRAVENOUS (VIG-IV) BUY AND ASSOCIATES SERVICES FOR UP TO 10 YEARS. | EMERGENT BIOSOLUTIONS CANADA INC | Department of Health and Human Services | — | Mar 23, 2026 | $422,315,784 |
| 75D30123C17978 CENTRALIZED VACCINE DISTRIBUTION | MCKESSON SPECIALTY DISTRIBUTION LLC | Department of Health and Human Services | TN | May 5, 2026 | $326,075,034 |
| 75A50119C00075 EO14042 BOTULISM ANTITOXIN | EMERGENT BIOSOLUTIONS CANADA INC | Department of Health and Human Services | — | Mar 30, 2026 | $320,923,453 |
| 75A50124C00057 ERVEBO PROCUREMENT | MERCK SHARP & DOHME LLC | Department of Health and Human Services | NJ | Sep 27, 2024 | $155,843,515 |
| 75A50323F80027 LEUKINE 250MCG QTY 14,635 AT THE UNIT PRICE OF $1,079.60 | PARTNER THERAPEUTICS, INC. | Department of Health and Human Services | MA | Mar 26, 2026 | $133,514,342 |
| 75A50324C00006 ADMINISTRATIVE OBJECT CLASS CODE DEOBLIGATION-ANTHIM (OBILTOXAXIMAB) | ELUSYS THERAPEUTICS INC | Department of Health and Human Services | NJ | Jun 1, 2026 | $124,523,123 |
| 75A50322F80030 THE PURPOSE OF THIS MODIFICATION IS TO DESCOPE AMOXICILLIN TRIHYDRATE 500 MG CLINS. | CHARTWELL RX LLC | Department of Health and Human Services | NY | Mar 24, 2026 | $99,047,470 |
| 75N90025C00008 ADDITIONAL FUNDING | DLA TROOP SUPPORT | Department of Health and Human Services | PA | Apr 2, 2026 | $93,536,123 |
| 75A50325F80036 PROCUREMENT OF XOFLUZA (BALOXAVIR MARBOXIL) 40MG AND 80MG TABLETS | GENENTECH USA, INC | Department of Health and Human Services | CA | Mar 17, 2026 | $74,970,000 |
| 75N98026C00026 PHARMACEUTICALS AND RELATED SUPPLIES UNITED STATES DEPARTMENT OF DEFENSE:1133869 [26-003472] | DLA TROOP SUPPORT | Department of Health and Human Services | PA | Apr 9, 2026 | $65,000,000 |
| HHSO10033001T IGF::OT::IGF | CANGENE CORPORATION | Department of Health and Human Services | — | Sep 16, 2013 | $63,304,734 |
| 75A50325F80003 EOI::EO: RADICAL TRANSPARENCY ABOUT WASTEFUL SPENDING::EOI TERMINATION FOR CONVENIENCE AGREEMENT AND CLOSEOUT MODIFICATION. | GENENTECH USA, INC | Department of Health and Human Services | CA | Mar 27, 2026 | $45,106,864 |
| 75A50325C00020 RAFA ATROPINE AUTO-INJECTORS (0.5 MG, 1 MG, AND 2 MG) | RAFA LABORATORIES LTD | Department of Health and Human Services | — | Sep 30, 2025 | $33,392,937 |
| 75A50326F80004 AMOXICILLIN TRIHYDRATE 500MG 60 CT AND 100 CT ORAL CAPSULES | USANTIBIOTICS LLC | Department of Health and Human Services | TN | May 27, 2026 | $29,998,678 |
| 75H71024F80289 MOD 4 - DEOBLIGATE CLIN 4 | MCKESSON CORPORATION | Department of Health and Human Services | TX | Mar 18, 2026 | $26,672,987 |
| 15B10626F00000037 MCKESSON: NON-CONTROLLED MEDICATION DOS: OCTOBER 1, 2025 THRU DECEMBER 31, 2025. | MCKESSON CORPORATION | Department of Justice | TX | Dec 3, 2025 | $24,731,493 |
| 75A50325C00002 NOVATION AND CHANGE-OF-NAME AGREEMENT | ACCORD BIOPHARMA, INC. | Department of Health and Human Services | CA | Mar 6, 2026 | $19,420,700 |
| 75A50325C00019 RELENZA (ZANAMIVIR) ROTADISK, 5MG | GLAXOSMITHKLINE, LLC | Department of Health and Human Services | NC | Jun 23, 2026 | $18,199,980 |
| 75A50324F80012 EOI::EO: RADICAL TRANSPARENCY ABOUT WASTEFUL SPENDING::EOI MODIFICATION TO ADJUST END DATE DUE TO OPTIONS NOT EXERCISED. | BIOCRYST PHARMACEUTICALS INC | Department of Health and Human Services | NC | Mar 27, 2026 | $13,877,674 |
Related records
Derived from awards these records share, ordered by how many.
Bought by
Performed in
- Ohio2,481
- Texas1,122
- New York474
- Illinois291
- Pennsylvania176
- New Jersey150
- Tennessee132
- California124
Sources and method
Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.
Totals cover awards where the government recorded this NAICS code. Codes are taken as reported; awards are never reclassified into a different code.
- 1Awards are grouped by the NAICS code the government recorded on the award, taken from USAspending.gov and last refreshed Aug 10, 2026. Miscoded awards stay miscoded here; we do not reassign codes.